High Levels of Recombinant CYP3A4 Expression in Chinese Hamster Ovary Cells Are Modulated by Coexpressed Human P450 Reductase and Hemin Supplementation

This publication has 24 references indexed in Scilit:

• Coexpression of a human P450 (CYP3A4) and P450 reductase generates a highly functional monooxygenase system in Escherichia coli
  Published by Wiley ,1999
• Recombinant DNA technology as an investigative tool in drug metabolism research
  Advanced Drug Delivery Reviews, 1996
• Roles of Divalent Metal Ions in Oxidations Catalyzed by Recombinant Cytochrome P450 3A4 and Replacement of NADPH-Cytochrome P450 Reductase with Other Flavoproteins, Ferredoxin, and Oxygen Surrogates
  Biochemistry, 1995
• Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1
  Pharmacogenetics, 1995
• Noninvasive tests of CYP3A enzymes
  Pharmacogenetics, 1994
• The Human Hepatic Cytochromes P450 Involved in Drug Metabolism
  Critical Reviews in Toxicology, 1992
• The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B₁ and comparison to CYP1A2 and CYP2A3
  Carcinogenesis: Integrative Cancer Research, 1991
• Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes
  Cell, 1986
• Destruction of heme and hemoproteins mediated by liver microsomal reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase
  Biochemistry, 1978
• The mechanism of liver microsomal lipid peroxidation
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1975